Back to Markets
SLSilence Therapeutics PLC

Silence Therapeutics PLC

SLNOTC MARKETS
Health CareBiotechnology

$6.90

+0.0400 (+0.58%)

As of 05/29/26 EDT · USD

Compare
Low: $4.19Current: $6.90High: $8.40

Key Statistics

Open

$6.75

Day High

$6.93

Day Low

$6.38

Prev. Close

$6.86

VolumeShares traded today.

208.87K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$325.92M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-4.34

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$8.40

52W LowLowest price over the past 52 weeks.

$4.19

50D MAAverage closing price over the last 50 trading days.

$6.57

200D MAAverage closing price over the last 200 trading days.

$6.00

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+6.3%

1M

-3.0%

6M

+8.7%

YTD

+12.2%

1Y

+18.2%

About

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

www.silence-therapeutics.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeOTC MARKETS
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade SLN

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.